Mar 082021
By Talent4Boards Team Talent4Boards - Great Talent builds Great Boards – USA, CA – Adicet Bio, Inc. (NASDAQ: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the appointment of Dr. Andrew Sinclair, Ph.D., to its board of directors, replacing Erez Chimovits, who will step down from the Board ... Adicet Bio welcomes Dr. Andrew Sinclair to its Board of Directors Adicet Bio welcomes Dr. Andrew Sinclair to its Board of Directors From:: Adicet Bio welcomes Dr. Andrew Sinclair to its Board of Directors
From:: Adicet Bio welcomes Dr. Andrew Sinclair to its Board of Directors
Sorry, the comment form is closed at this time.